|
|
Other links at Articles > Business of Medicine |
| 1. |
Judge Denies Class in Fosamax Cases Against Merck
|
|
|
A U.S. federal judge has denied motions to certify classes of users of osteoporosis drug Fosamax who wanted Merck & Co to set up a program to monitor them for an ailment involving jaw bone decay. Reuters Health Information
|
| 4. |
International Approvals: Isentress, Rexin-G, Vectibix
|
|
|
Europe has approved raltegravir tablets (Isentress); the Philippines has approved a tumor-targeted gene delivery product (Rexin-G); and Europe has approved panitumumab intravenous infusion (Vectibix). Medscape Medical News
|
| 5. |
Massachusetts Law Spurs Rise in Health Coverage
|
|
|
Nearly half a million people obtained health insurance in the 2 years since Massachusetts enacted a pioneering health-care law, officials said on Tuesday, putting the state closer to covering nearly all residents. Reuters Health Information
|
|
|